These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9083894)

  • 1. Combined heterozygous deficiency of the classical complement pathway proteins C2 and C4.
    Hartmann D; Fremeaux-Bacchi V; Weiss L; Meyer A; Blouin J; Hauptmann G; Kazatchkine M; Uring-Lambert B
    J Clin Immunol; 1997 Mar; 17(2):176-84. PubMed ID: 9083894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
    Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE).
    Dragon-Durey MA; Rougier N; Clauvel JP; Caillat-Zucman S; Remy P; Guillevin L; Liote F; Blouin J; Ariey F; Lambert BU; Kazatchkine MD; Weiss L
    Clin Exp Immunol; 2001 Jan; 123(1):133-9. PubMed ID: 11168010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
    Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lupus and protein deficiencies of the classical complement pathway].
    Weiss L; Maillet F; Kazatchkine M
    Rev Prat; 1990 Sep; 40(21):1937-40. PubMed ID: 2237185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo.
    Venneker GT; Westerhof W; de Vries IJ; Drayer NM; Wolthers BG; de Waal LP; Bos JD; Asghar SS
    J Invest Dermatol; 1992 Dec; 99(6):853-8. PubMed ID: 1469300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus.
    Goldstein R; Arnett FC; McLean RH; Bias WB; Duvic M
    Arthritis Rheum; 1988 Jun; 31(6):736-44. PubMed ID: 3260100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intricate role of complement component C4 in human systemic lupus erythematosus.
    Yang Y; Chung EK; Zhou B; Lhotta K; Hebert LA; Birmingham DJ; Rovin BH; Yu CY
    Curr Dir Autoimmun; 2004; 7():98-132. PubMed ID: 14719377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC.
    Christiansen FT; Zhang WJ; Griffiths M; Mallal SA; Dawkins RL
    J Rheumatol; 1991 Sep; 18(9):1350-8. PubMed ID: 1757937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.
    Fielder AH; Walport MJ; Batchelor JR; Rynes RI; Black CM; Dodi IA; Hughes GR
    Br Med J (Clin Res Ed); 1983 Feb; 286(6363):425-8. PubMed ID: 6401549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical pathway deficiencies - A short analytical review.
    Truedsson L
    Mol Immunol; 2015 Nov; 68(1):14-9. PubMed ID: 26038300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of C4 isotypes and factor B in type I C2 deficiency suggest haplotype-dependent quantitative expression of MHC class III complement genes.
    Truedsson L; Gullstrand B; Jönsson T; Klint C
    Exp Clin Immunogenet; 1995; 12(2):66-73. PubMed ID: 7576717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus.
    Reveille JD; Arnett FC; Wilson RW; Bias WB; McLean RH
    Immunogenetics; 1985; 21(4):299-311. PubMed ID: 3873410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C4 null alleles in childhood onset systemic lupus erythematosus. Is there any relationship with renal disease?
    Clemenceau S; Castellano F; Montes de Oca M; Kaplan C; Danon F; Levy M
    Pediatr Nephrol; 1990 May; 4(3):207-12. PubMed ID: 2400645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the disease-associated complement C4 gene from the HLA-A1, B8, DR3 haplotype.
    Ulgiati D; Abraham LJ
    Exp Clin Immunogenet; 1996; 13(1):43-54. PubMed ID: 8854088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA analysis in a MHC heterozygous patient with complete C4 deficiency--homozygosity for C4 gene deletion and C4 pseudogene.
    Nordin Fredrikson G; Truedsson L; Sjöholm AG; Kjellman M
    Exp Clin Immunogenet; 1991; 8(1):29-37. PubMed ID: 1910860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited deficiency of the fourth component of human complement.
    Hauptmann G; Tappeiner G; Schifferli JA
    Immunodefic Rev; 1988; 1(1):3-22. PubMed ID: 3078708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in the structural basis of the human complement C4A null allele (C4A Q0) as revealed by HindIII restriction fragment length polymorphism analysis.
    Uring-Lambert B; Vegnaduzzi N; Carroll MC; Tongio MM; Goetz J; Hauptmann G
    FEBS Lett; 1987 Jun; 217(1):65-8. PubMed ID: 2885219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement allotyping in SLE: association with C4A null.
    Christiansen FT; Dawkins RL; Uko G; McCluskey J; Kay PH; Zilko PJ
    Aust N Z J Med; 1983 Oct; 13(5):483-8. PubMed ID: 6606418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.